Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

Details

Language :

English

ISSN :

00097322 and 15244539

Volume :

149

Issue :

6

Database :

Supplemental Index

Journal :

Circulation (Ovid)

Publication Type :

Periodical

Accession number :

ejs65519793

Full Text :

https://doi.org/10.1161/CIRCULATIONAHA.123.067584